(Q50764182)

18 March 2018

title

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. (English)

1 reference

18 March 2018

0 references

5

1 reference

18 March 2018

Albert D. Windhorst

7

1 reference

18 March 2018

Wiesje van der Flier

Wiesje M van der Flier

11

0 references

Adriaan A Lammertsma

Adriaan A Lammertsma

9

0 references

Philip Scheltens

10

Philip Scheltens

1 reference

18 March 2018

8

Frederik Barkhof

1 reference

18 March 2018

1

Rik Ossenkoppele

1 reference

18 March 2018

Bart N M van Berckel

12

Bart N M van Berckel

1 reference

18 March 2018

Sofie M Adriaanse

4

Sofie F Adriaanse

1 reference

18 March 2018

Nelleke Tolboom

2

Nelleke Tolboom

1 reference

18 March 2018

Jessica Foster-Dingley

3

Jessica C Foster-Dingley

1 reference

18 March 2018

Maqsood Yaqub

6

Maqsood Yaqub

1 reference

18 March 2018

publication date

23 March 2012

1 reference

18 March 2018

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 March 2018

volume

39

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

page(s)

990-1000

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s00259-012-2102-3

exact match

0 references

cites work

Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

PET imaging of amyloid deposition in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Synthesis of 2-(1,1-dicyanopropen-2-yl)-6-(2-[18F]-fluoroethyl)-methylamino-naphthalene ([18F]FDDNP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

MR-based automatic delineation of volumes of interest in human brain PET images using probability maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Simplified parametric methods for [11C]PIB studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Simplified parametric methods for [18F]FDDNP studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Longitudinal changes of CSF biomarkers in memory clinic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2102-3

21 January 2018

1 reference

12 December 2020

Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay

1 reference

12 December 2020

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

1 reference

12 December 2020

Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.

1 reference

12 December 2020

10.1007/S00259-012-2102-3

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018